![Ming Hao Sun](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ming Hao Sun
Direttore Tecnico/Scientifico/R&S presso
CAPRICOR THERAPEUTICS, INC.
Profilo
Ming Hao Sun is Senior Vice President-Quality Control & Research at Capricor Therapeutics, Inc. since 2021.
Former roles include Director-Stem Cell Research at Trans Ova Genetics LC from 2019 to 2020 and General Manager-San Diego Site at Precigen, Inc. from 2012 to 2019.
Education includes a doctorate from The Pennsylvania State University and undergraduate and graduate degrees from Wuhan University.
Posizioni attive di Ming Hao Sun
| Società | Posizione | Inizio |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2021 |
Precedenti posizioni note di Ming Hao Sun
| Società | Posizione | Fine |
|---|---|---|
Trans Ova Genetics LC
 Trans Ova Genetics LC Medical SpecialtiesHealth Technology Develops embryo transfer technologies to vitro fertilization for animals | Corporate Officer/Principal | 01/05/2020 |
| PRECIGEN, INC. | Corporate Officer/Principal | 01/08/2019 |
Formazione di Ming Hao Sun
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
35
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Wuhan University
 Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Trans Ova Genetics LC
Trans Ova Genetics LC Medical SpecialtiesHealth Technology Develops embryo transfer technologies to vitro fertilization for animals | Health Technology |
